Effect of Hyoscine butylbromide on the rate of cervical dilatation in labour.

Effect of hyoscine butylbromide on the rate of cervical dilatation in active phase of labour: a randomized control trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201403000779211

Enrollment

160

Registered

2014-03-04

Start date

2014-02-10

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth The labour process and progress

Interventions

Hyoscine butyl bromide

Normal Saline

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Parturients aged 18-35 years Singleton pregnancies Term pregnancies( between 37 completed weeks and 41 weeks) Active phase of labour.

Exclusion criteria

Exclusion criteria: Post-term or preterm pregnancies Abnormal fetal lie or presentation Complicated pregnancies Previous uterine scar Pre-labour rupture of membrane Glaucoma Myasthena gravis Obstructive uropathy Paralytic pileus Allergy to Hyoscine or excipients

Design outcomes

Primary

Measure	Time frame
duration of first stage of labour	—

Secondary

Measure	Time frame
duration of second stage of labour;duration of third stage of labour;occurence of primary postpartum haemorrhage	—

Countries

Nigeria

Contacts

Public ContactOlusegun Badejoko

FMCOG,FWACS. Consultant Obstetrician and Gynaecologist

oobmed@yahoo.com08034919210

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026